NET RESEARCH FOUNDATION RELEASES REQUEST FOR PROPOSALS FOR $1.2 MILLION GRANTS TO CONTROL AND CURE NEUROENDOCRINE TUMORS

The Neuroendocrine Tumor Research Foundation (NETRF) is pleased to announce its request for proposals (RFP) for breakthrough “Accelerator Grants” to advance its vital mission to cure neuroendocrine cancers (NETs). With these grants, NETRF is launching the most ambitious privately funded global research effort ever undertaken to control and cure neuroendocrine cancers.

NETRF is seeking proposals for significant NET research projects, with each grant award of up to $1.2 million over four years. “NETRF seeks to fund the most dedicated teams and robust proposals to transform the landscape of NET research,” said Lauren Erb, NETRF Director of Research. Inspired by the generous funding received from the Margie and Robert E. Petersen Foundation, NETRF created the ‘Accelerator Grants’ as a tribute to automobile publishing giant Robert E. Petersen, who passed away from neuroendocrine cancer in 2007. “We understand that strong, peer-reviewed research takes time, but we also understand the urgency that our patients and families feel," said Ron Hollander, NETRF Executive Director. "Our commitment is to reach out to researchers internationally to bring the best ideas and attract leading investigators to hopefully move our drive for better treatments and cures into the fast lane." READ MORE

NETRF FUNDS INAUGURAL NETS NUCLEAR MEDICINE RESEARCH GRANT
Award for The Education and Research Foundation for Nuclear Medicine and Molecular Imaging

In a new collaboration with The Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF), NETRF is proud to support an inaugural NETS Nuclear Medicine Research Grant. This grant was made possible by the generous support of the Margie and Robert E. Petersen Foundation. The grant is designed to help a basic or clinical scientist in the early stages of his or her career conduct novel and innovative research focused on the diagnosis and treatment of neuroendocrine tumors. The grant will provide $50,000 to ERF for a one-year award. READ MORE

SAVE THE DATE
November 10, 2016: NYC NET Patient Education Conference

Tuesday, November 10, 2016
Einstein College of Medicine
Robbins Auditorium
Details, registration information, and agenda will be available shortly.

INCA SUMMIT FOCUSED ON COLLABORATION BETWEEN PATIENT GROUPS AND RESEARCH LEADERS

Blog Post by Ron Hollander

At the recent International Neuroendocrine Cancer Alliance (INCA) Summit, patient groups had the opportunity to connect and collaborate with clinical and research leaders from across the world. This was the first summit to take place after the completion of INCA’s strategic plan, which centers on a vision that all patients globally should have access to the best care and most current research. READ MORE